Physician profile
Joseph Ortiz
NPI 1689759029
$1,518.47
in general payments reported to CMS, 2019-2025
28 companies · $83.08 in 2025
The $83.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $83.83 · 2021: $231 · 2022: $334 · 2023: $260 · 2024: $91.45 · 2025: $83.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $434.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $226.55 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $221.87 | 2019-2024 | |
| Abbvie INC. | $185.70 | 2019-2022 | |
| Davol INC. | $69.28 | 2021 | |
| Organon LLC | $64.53 | 2022-2025 | Nexplanon, Jada System |
| Aspira Women'S Health INC | $63.06 | 2020-2024 | Ova1 |
| Sumitomo Pharma America, INC. | $61.84 | 2023-2025 | Myfembree |
| Gynesonics, INC. | $60.11 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $52.44 | 2022-2023 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Pfizer INC. | $41.79 | 2023-2025 | |
| Therapeuticsmd, INC. | $40.22 | 2019-2021 | |
| Myovant Sciences INC. | $37.83 | 2022 | |
| Exeltis, USA INC. | $34.54 | 2025 | Slynd |
| Amag Pharmaceuticals, INC. | $33.84 | 2019 | |
| Minerva Surgical, INC | $33.50 | 2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $30.93 | 2019-2022 | |
| Intuitive Surgical, INC. | $30.57 | 2022 | |
| Medtronic, INC. | $30.54 | 2021-2023 | Truclear |
| Avion Pharmaceuticals | $29.61 | 2019-2021 | |
| Becton, Dickinson and Company | $27.34 | 2021 | |
| Roche Diagnostics Corporation | $23.59 | 2021 | |
| Olympus America INC. | $22.74 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $19.75 | 2023 | Vivjoa |
| Covidien LP | $19.36 | 2019 | |
| Allergan, INC. | $16.55 | 2019 | |
| Smith+Nephew, INC. | $16.41 | 2021 | |
| Coloplast Corp | $12.52 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.